UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)
Go back to UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 143.99 -1.56 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.55 | 52 Week High | $0.52 | |||
| Open | $145.98 | 52 Week Low | $0.08 | |||
| Day High | $147.50 | P/E | N/A | |||
| Day Low | $140.50 | EPS | $-3.80 | |||
| Volume | 5,902,998 | |||||
